ALB vs HOLX · rev $1.74B vs P/E 32, rev $4.10B
Albemarle Corp (ALB) versus Hologic Inc (HOLX) — a side-by-side from cached financials, not a winner call.
Albemarle Corp (ALB) is a specialty chemicals company listed on US.
Hologic Inc (HOLX) is a medical instruments & supplies company listed on NASDAQ.
Latest reported ALB revenue for 2026-06-30 was $1.74B. Net income was $480.0M. Revenue was up 22.0% from 2026-03-31 to 2026-06-30. ALB currently screens at market cap $8.00B.
Latest reported HOLX revenue for 2025-09-27 was $4.10B. Net income was $565.7M. Revenue was up 1.7% from 2024-09-28 to 2025-09-27. HOLX currently screens at market cap $16.97B and trailing P/E 31.5.
ALB currently screens at market cap $8.00B. HOLX currently screens at market cap $16.97B and trailing P/E 31.5.
Not investment advice. Open the ALB and HOLX stock pages for the full models.
Not investment advice.